FundedIQ
Biotechnology

60 Degrees Pharma: Funding, Investors & Team (Sep 2026)

60 Degrees Pharmaceuticals creates and markets innovative medications for the treatment and prevention of infectious diseases. Among their offerings are ARAKODA for malaria prevention and COVID-19 treatments.

60degreespharma.com LinkedIn Washington, United States 1-10 employees
Total raised
$7.8M
Rounds
3
Latest
Undisclosed round
Jul 2025

60 Degrees Pharma has raised $7.8M across 3 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Jul 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

60 Degrees Pharma Company Profile and Key Stats

Total funding raised
$7.8M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$5.0M in Jul 2025
Employees
1-10
reported band
Headquarters
Washington, United States

Latest funding round on record: Jul 2025.

60 Degrees Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
$5.0M
Undisclosed round
$1.0M
Undisclosed round
$1.8M

60 Degrees Pharma raised $1.8M in an undisclosed round announced in May 2023.

1.7 years later, an undisclosed round of $1.0M was announced in Jan 2025.

6 months later, an undisclosed round of $5.0M was announced in Jul 2025.

60 Degrees Pharma Founders and Leadership Team

Name
Role
Contact
Geoffrey Dow
Founder
—

No contact details are on record for this team yet.

60 Degrees Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.0M
30,076
$7.5M

60 Degrees Pharma's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like 60 Degrees Pharma in Biotechnology and Washington

Companies Similar to 60 Degrees Pharma

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…

Undisclosed round $12.0M

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

60 Degrees Pharma Funding FAQs

What does 60 Degrees Pharma do?

60 Degrees Pharmaceuticals creates and markets innovative medications for the treatment and prevention of infectious diseases. Among their offerings are ARAKODA for malaria prevention and COVID-19 treatments.

How much funding has 60 Degrees Pharma raised?

60 Degrees Pharma has raised $7.8M across 3 rounds on record. The most recent is an undisclosed round of $5.0M announced in Jul 2025.

When did 60 Degrees Pharma last raise funding?

60 Degrees Pharma's most recent funding round on record is an undisclosed round of $5.0M, announced in Jul 2025.

Who founded 60 Degrees Pharma?

FundedIQ lists Geoffrey Dow (Founder) at 60 Degrees Pharma.

Where is 60 Degrees Pharma headquartered?

60 Degrees Pharma is based in Washington, District of Columbia, United States.

How many employees does 60 Degrees Pharma have?

60 Degrees Pharma is in the 1-10 employee band.

How does 60 Degrees Pharma's funding compare to other Biotechnology startups?

60 Degrees Pharma's latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's 60 Degrees Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 60 Degrees Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.